A patient presents to the ER with C/O HA and LBP. The patient has a h/o neuropathy and hypopnea. She currently has no N/V and VSS. After UA is performed, it is determined the patient has a UTI and will be prescribed cap to be taken t. i.d.

Anurse is teaching about a new prescription for infliximab to a client who has rheumatoid arthritis. which of the following information should the nurse include in the teaching? a. “you will receive a mantoux test before the initial medication dose.” b. “you might experience diarrhea during the first 2 weeks of treatment.” c. “you will receive the medication every week for 6 weeks.” d. “you should receive the intranasal influenza vaccine.”